Live Breaking News & Updates on ஸ்ம் பாலொ புத்தாண்தான் நிறுவனம்
Stay updated with breaking news from ஸ்ம் பாலொ புத்தாண்தான் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brazil authorizes Butanvac vaccine shot for volunteers in clinical trial By Syndicated Content Jul 7, 2021 | 4:52 PM BRASILIA (Reuters) – Brazilian health regulator Anvisa on Wednesday gave the go-ahead for the Butanvac vaccine developed by Sao Paulo’s Butantan Institute biomedical center to be used on volunteers as part of clinical trials. In a statement, Anvisa said the vaccine will be applied in two doses, 28 days apart. Phase 1 of Butanvac’s clinical trial will involve 400 volunteers, and the first two phases are expected to have 6,000 volunteers in total. (Reporting by Jamie McGeever; Editing by Leslie Adler) ); } return false; }); $( #comments .commentlist .comment-content a ).attr( target , blank ); ....
Reuters 1 minute read BRASILIA, July 7 (Reuters) - Brazilian health regulator Anvisa on Wednesday gave the go-ahead for the Butanvac COVID-19 vaccine developed by Sao Paulo s Butantan Institute biomedical center to be used on volunteers in clinical trials. Anvisa in a statement said the vaccine will be applied in two doses, 28 days apart. Phase I of Butanvac s clinical trial will involve 400 volunteers, and the first two phases are expected to involve 6,000 volunteers in total. In a separate statement, Butantan said the tests will begin in the coming days in Riberao Preto, a city in the state of Sao Paulo. Butantan said it has around 10 million doses of the Butanvac shot in stock, which will be used to assess the vaccine s safety and efficacy in the trials. It hopes to have 40 million shots ready for use by October, it added. ....
Brazil authorizes Butanvac vaccine for volunteers in cl... dailymaverick.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymaverick.co.za Daily Mail and Mail on Sunday newspapers.
BRASILIA (REUTERS) - The chief executive of Sinovac Biotech Ltd, the main supplier of Covid-19 vaccines to Brazil, complained last month to Brazilian diplomats in Beijing that anti-China comments in Brasilia were not helping with delayed shipments, two people with knowledge of the matter told Reuters. Sinovac CEO Yin Weidong suggested an official retraction would make for a more fluid relationship between China and Brazilian President Jair Bolsonaro, the sources said. Bolsonaro, who complained during his 2018 campaign about a string of Chinese acquisitions in Brazil, said in a speech on May 5 that the coronavirus pandemic could be chemical warfare waged by the fastest growing nation, without naming China. ....
Sinovac CEO complained about anti-China comments in Brazil: Report Toggle share menu Advertisement Sinovac CEO complained about anti-China comments in Brazil: Report Sinovac Biotech chairman and CEO Yin Weidong attends a government-organized media tour showcasing the company s development of a coronavirus disease (COVID-19) vaccine candidate in Beijing, China, Sep 24, 2020. (Photo: REUTERS/Thomas Peter) 10 Jun 2021 07:05AM Share this content Bookmark BRASILIA: The chief executive of Sinovac Biotech, the main supplier of COVID-19 vaccines to Brazil, complained last month to Brazilian diplomats in Beijing that anti-China comments in Brasilia were not helping with delayed shipments, two people with knowledge of the matter told Reuters. ....